Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cha

Showing results (621-630 of 667) with videos related to

Pageof 67
Sort By:
Psychiatry Research. Neuroimaging|January 28, 2023
Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesityHartej Gill, Roger S McIntyre, Colin Hawco, et al.
CNS Spectrums|December 10, 2020
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulationNelson B Rodrigues, Ashley Siegel, Orly Lipsitz, et al.
Journal of Affective Disorders|October 11, 2016
Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label studyRodrigo B Mansur, Juhie Ahmed, Danielle S Cha, et al.
Journal of Affective Disorders|December 26, 2016
A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorderDanielle S Cha, Michael W Best, Christopher R Bowie, et al.
Journal of Immigrant and Minority Health|December 27, 2015
Diabetes Knowledge, Attitudes and Behaviors Among Somali and Latino ImmigrantsJane W Njeru, Christine M Formea, Ahmed Osman, et al.
Journal of Pain and Symptom Management|August 31, 2018
Improving Value of Care for Older Adults With Advanced Medical Illness and Functional Decline: Cost Analyses of a Home-Based Palliative Care ProgramChristina Y Chen, James M Naessens, Paul Y Takahashi, et al.
Transplantation|June 8, 2001
beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitusJ H Nam, J I Mun, S I Kim, et al.
Journal of Affective Disorders|June 23, 2021
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 22, 2021
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case SeriesOrly Lipsitz, Joshua D Di Vincenzo, Nelson B Rodrigues, et al.
Diabetes, Obesity & Metabolism|January 13, 2015
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extensionS-M Jin, C-Y Park, Y M Cho, et al.
Pageof 67

Showing results (621-630 of 667) with videos related to

Sort By:
Pageof 67
Psychiatry Research. Neuroimaging|January 28, 2023
Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesityHartej Gill, Roger S McIntyre, Colin Hawco, et al.
CNS Spectrums|December 10, 2020
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulationNelson B Rodrigues, Ashley Siegel, Orly Lipsitz, et al.
Journal of Affective Disorders|October 11, 2016
Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label studyRodrigo B Mansur, Juhie Ahmed, Danielle S Cha, et al.
Journal of Affective Disorders|December 26, 2016
A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorderDanielle S Cha, Michael W Best, Christopher R Bowie, et al.
Journal of Immigrant and Minority Health|December 27, 2015
Diabetes Knowledge, Attitudes and Behaviors Among Somali and Latino ImmigrantsJane W Njeru, Christine M Formea, Ahmed Osman, et al.
Journal of Pain and Symptom Management|August 31, 2018
Improving Value of Care for Older Adults With Advanced Medical Illness and Functional Decline: Cost Analyses of a Home-Based Palliative Care ProgramChristina Y Chen, James M Naessens, Paul Y Takahashi, et al.
Transplantation|June 8, 2001
beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitusJ H Nam, J I Mun, S I Kim, et al.
Journal of Affective Disorders|June 23, 2021
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 22, 2021
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case SeriesOrly Lipsitz, Joshua D Di Vincenzo, Nelson B Rodrigues, et al.
Diabetes, Obesity & Metabolism|January 13, 2015
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extensionS-M Jin, C-Y Park, Y M Cho, et al.
Pageof 67